Introduction to Tesamorelin for Research
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), specifically engineered as a 44‑amino‑acid sequence that corresponds to the N‑terminal portion of human GHRH with a trans‑3‑hexenoyl group attached at the N‑terminus. This modification extends the peptide’s half‑life in experimental systems and enhances binding affinity to the GHRH receptor. Researchers employ tesamorelin to probe the regulatory networks that govern pulsatile growth hormone (GH) secretion from the anterior pituitary. Because the peptide mimics endogenous GHRH, it serves as a selective tool to isolate receptor‑mediated signalling cascades without confounding cross‑reactivity with other hypothalamic factors.
Laboratories utilise the compound in cell‑based assays, perfused pituitary models, and in vivo models to map downstream effectors such as insulin‑like growth factor 1 (IGF‑1) and to dissect feedback loops that involve somatostatin. The peptide is supplied solely for laboratory research purposes; it is not manufactured or approved for human or veterinary use. Any handling must comply with local institutional biosafety and chemical hygiene regulations.
Why Choose a Research Grade Supplier
Selecting a research grade supplier for tesamorelin is critical to obtaining reproducible and interpretable data. Research grade designations imply that the manufacturer adheres to rigorous in‑process controls, characterisation protocols, and documentation standards that are absent from non‑specialist sources. The following elements distinguish a qualified supplier:
Stringent Purity and Molecular Weight Verification
A dependable supplier confirms peptide identity and homogeneity through orthogonal analytical techniques. High‑performance liquid chromatography (HPLC) quantifies purity, typically reporting values ≥98 %, while electrospray ionisation mass spectrometry (ESI‑MS) or matrix‑assisted laser desorption/ionisation (MALDI‑MS) validates the molecular weight within an acceptable mass error (e.g., ±1 Da). For tesamorelin, the expected monoisotopic mass is approximately 5135.8 g/mol, and any batch‑to‑batch variability must be transparently reported.
Comprehensive Quality Control Documentation
Every shipment from a research grade supplier includes a Certificate of Analysis (CoA) that details:
- HPLC chromatogram with integration parameters
- Mass spectrum and observed m/z values
- Peptide content by amino acid analysis or UV spectrophotometry
- Counter‑ion identity (e.g., acetate) and residual solvent levels
- Storage recommendations and retest date
The CoA guarantees batch traceability, enabling researchers to correlate experimental outcomes with a specific production lot and to requalify the material during long‑term studies.
Stability and Handling Expertise
Research grade suppliers provide handling guidelines that reflect stress‑testing data. They advise on solvent compatibility, freeze‑thaw stability, and protection from light and moisture. Such guidance minimizes degradation artefacts that could confound dose‑response relationships in sensitive assays.
Quality Standards for Tesamorelin
To ensure that tesamorelin meets the demands of modern molecular endocrinology, laboratories should set minimum acceptance specifications. Reputable suppliers align with these criteria:
Purity and Peptide Content
HPLC purity is routinely specified at ≥98 % (area under the curve at 214 nm or 220 nm). However, purity alone does not account for counter‑ions, water, or residual synthesis by‑products. The peptide content—typically expressed as a percentage of the total lyophilised mass—should be documented. For tesamorelin acetate, for instance, the net peptide content often ranges between 75 % and 85 %, with the remainder comprised of acetate and bound water. Accurate total peptide content allows researchers to calculate the molar amount of active peptide used in reconstitution, an essential step for inter‑study consistency.
Salt Form and Solubility
Tesamorelin is most commonly supplied as the acetate salt, which offers favourable solubility in aqueous buffers at neutral pH. Suppliers should state the counter‑ion type and the average acid content, as these parameters affect the final peptide concentration in stock solutions. Researchers requiring a different salt form (e.g., trifluoroacetate) for particular solvent systems can request custom synthesis through advanced supplier programmes.
Storage and Stability
Lyophilised tesamorelin is stable when stored at −20 °C or below in a desiccated environment. Upon receipt, vials should be equilibrated to ambient temperature before opening to prevent moisture condensation. Once reconstituted, the peptide solution should be aliquoted and stored at −80 °C to minimise proteolytic degradation and aggregation. Repeated freeze‑thaw cycles must be avoided; single‑use aliquoting is strongly recommended. Suppliers will specify a retest period based on real‑time and accelerated stability studies, often 12–24 months from the date of manufacture for the lyophilised form.
Endotoxin and Bioburden Control
For cell‑based or in vivo research models, low endotoxin levels are critical. Research grade tesamorelin is typically subjected to endotoxin testing (LAL assay), with acceptance limits ≤1 EU/mg. Some suppliers also provide a Certificate of Sterility if aseptic processing has been performed, although most peptides are supplied non‑sterile and the end‑user must filter the reconstituted solution through a 0.2 µm membrane before use in sensitive biological systems.
Applications in Research
Tesamorelin’s selective activation of the GHRH receptor makes it a versatile tool across several domains of preclinical investigation. The following examples illustrate current laboratory applications—all conducted under controlled research conditions and never in human subjects.
Growth Hormone Axis and Neuroendocrinology
Investigators use tesamorelin in primary pituitary cell cultures and hypothalamic slice preparations to delineate GHRH‑dependent signalling pathways. By measuring GH release via ELISA or RIA, studies probe factors such as intracellular cAMP accumulation, calcium flux, and phosphorylation of CREB. Comparative experiments with somatostatin or ghrelin analogues help map the interplay between stimulatory and inhibitory inputs that shape ultradian GH pulses.
Adipose Tissue Dynamics and Lipid Metabolism
In adipocyte cell lines and rodent models, tesamorelin is applied to examine how enhanced GH secretion influences lipolysis, adipokine profiles, and regional fat distribution. Research focuses on visceral adipose tissue reduction and the molecular mechanisms linking GHRH receptor activation to hormone‑sensitive lipase and perilipin expression. Such studies often incorporate IGF‑1 measurement to distinguish direct GH effects from downstream IGF‑1‑mediated actions.
IGF‑1 Signalling in Metabolic Pathways
Tesamorelin‑driven GH secretion raises circulating and local IGF‑1 levels, providing a physiological method to study IGF‑1 receptor activation in muscle, bone, and liver. Laboratory models explore how this axis affects mitochondrial biogenesis, protein synthesis, and glucose homeostasis. These investigations are conducted in transgenic animals or ex vivo tissue assays, with careful controls to isolate peptide‑specific responses.
Preclinical Models of Endocrine Dysfunction
Finally, tesamorelin is deployed in animal models of relative GH deficiency or altered somatotroph function. Researchers monitor endpoints such as body composition, bone mineral density, and cognitive performance in aging or surgically modified animals. The peptide’s defined structure and receptor selectivity allow for cleaner interpretation of results compared to crude GHRH extracts or less specific secretagogues.
How to Order from a Research Grade Supplier
Procurement of research grade tesamorelin follows a structured process designed to confirm the buyer’s legitimate research intent and to ensure the peptide arrives in optimal condition. Below is a step‑by‑step guide typical of major international suppliers.
1. Institutional Verification
To comply with international regulations and supplier policies, first‑time purchasers must provide evidence of affiliation with a recognised research institution, university, or pharmaceutical company. Acceptable credentials include a verifiable institutional email address, a copy of the organisation’s operating licence, or a statement of research purpose on official letterhead. This step is not a regulatory hurdle; it is a safeguard that restricts distribution to authorised laboratories engaged in legitimate scientific investigation.
2. Specify Product Configuration
When placing an order, researchers must indicate:
- Quantity, usually expressed in milligrams or grams (typical research orders range from 10 mg to 100 mg)
- Salt form (acetate is standard, but other counter‑ions may be available on request)
- Vial size and packaging (e.g., single 10‑mg vial or bulk pack)
- Any additional testing requirements, such as endotoxin quantification or heavy metal analysis
Bespoke synthesis services may also offer amino‑acid composition analysis, peptide sequencing (Edman degradation or MS/MS), or circular dichroism spectroscopy for secondary structure confirmation at an additional cost.
3. Shipping and Lead Time
Tesamorelin lyophilised powder is typically shipped at ambient temperature with a desiccant pack, as the peptide remains stable for transit durations of several days. However, for extended journeys or extreme climates, refrigerated cold packs may be included. Express courier (FedEx, DHL, UPS) is the norm, with shipments fully tracked and visible to the customer. Lead times vary from same‑day dispatch for in‑stock catalogue items to 2–4 weeks for custom synthesis batches. The supplier will advise on transit times and help the customer coordinate receipt so the material can be placed immediately in −20 °C storage upon arrival.
4. Documentation and After‑Sale Support
Upon dispatch, the customer receives a digital copy of the CoA and, if requested, a formal quotation or proforma invoice to facilitate internal procurement processing. The supplier’s technical support team remains available to address questions about reconstitution buffers, solubility challenges, or peptide storage. Reputable suppliers also maintain batch reserve samples for a defined period, allowing re‑testing should any discrepancy arise in the customer’s laboratory.
Research Use Only Note: This product is intended exclusively for in vitro laboratory research and experimental model studies. It is not manufactured, labelled, or approved for any diagnostic, therapeutic, veterinary, or human application. Purchasers must ensure that all handling complies with applicable national and institutional regulations governing research chemicals.
For research use only. Not for human or veterinary use.
